Distinct higher-order alpha-synuclein oligomers induce intracellular aggretation by Illes-toth, Eva et al.
Distinct higher-order alpha-synuclein oligomers induce 
intracellular aggretation
ILLES-TOTH, Eva, RAMOS, Mafalda, CAPPAI, Roberto, DALTON, Caroline 
and SMITH, David
Available from Sheffield Hallam University Research Archive (SHURA) at:
http://shura.shu.ac.uk/10364/
This document is the author deposited version.  You are advised to consult the 
publisher's version if you wish to cite from it.
Published version
ILLES-TOTH, Eva, RAMOS, Mafalda, CAPPAI, Roberto, DALTON, Caroline and 
SMITH, David (2015). Distinct higher-order alpha-synuclein oligomers induce 
intracellular aggretation. Biochemical Journal, 468 (3), 485-493. 
Repository use policy
Copyright © and Moral Rights for the papers on this site are retained by the 
individual authors and/or other copyright owners. Users may download and/or print 
one copy of any article(s) in SHURA to facilitate their private study or for non-
commercial research. You may not engage in further distribution of the material or 
use it for any profit-making activities or any commercial gain.
Sheffield Hallam University Research Archive
http://shura.shu.ac.uk
Biochem. J. (2015) 468, 485–493 doi:10.1042/BJ20150159 485
Distinct higher-order α-synuclein oligomers induce intracellular
aggregation
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Misfolding and aggregation of α-synuclein (α-syn) into Lewy
bodies is associated with a range of neurological disorders,
including Parkinson’s disease (PD). The cell-to-cell transmission
of α-syn pathology has been linked to soluble amyloid oligomer
populations that precede Lewy body formation. Oligomers
produced in vitro under certain conditions have been demonstrated
to induce intracellular aggregation in cell culture models. In the
present study, we characterize, by ESI–ion mobility spectrometry
(IMS)–MS, a specific population of α-syn oligomers. These
MS-compatible oligomers were compared with oligomers with
known seeding and pore-forming capabilities and were shown
to have the ability to induce intracellular aggregation. Each
oligomer type was shown to have distinct epitope profiles that
correlated with their toxic gain-of-function. Structurally, the MS
compatible oligomers populated a range of species from dimers
through to hexamers. Lower-order oligomers were structurally
diverse and consistent with unstructured assemblies. Higher-order
oligomers were shown to be compact with ring-like structures. The
observation of this compact state may explain how this natively
disordered protein is able to transfer pathology from cell to cell
and avoid degradation by cellular proteases.
Key words: α-synuclein, aggregation, amyloid, ion mobility, mass
spectrometry (MS), oligomer.
INTRODUCTION
α-Synuclein (α-syn) instigates both sporadic and idiopathic
Parkinson’s disease (PD) by various modes of action [1] and is the
major component of intracellular Lewy bodies and Lewy neurites
in the brain [2]. The three rare missense mutations ofα-syn (A30P,
A53T and E46K), copy number variants and two probable substi-
tutions (H50Q and G51D) are associated with familial PD, indic-
ating a central role for this protein [3]. Growing evidence suggests
that soluble oligomeric forms of α-syn, which precede amyloid
formation, are causative triggers for the dopaminergic cell loss
occurring in PD [4,5]. The morphology and associated mode of
toxicity displayed by alternative types of α-syn oligomers are
largely dependent on the environmental conditions under which
they have been prepared [6–11]. Numerous in vitro and in vivo
studies onα-syn oligomers have demonstrated that a toxic gain-of-
function occurs in the disease state via two main mechanisms: (i)
Ca2+ imbalances caused by the formation of pore-like complexes
within lipid membranes, and (ii) transmembrane seeding that then
results in intracellular aggregation [1]. α-Syn is expressed as an
intracellular protein but has been shown to be directly secreted
or released as a result of neuronal death or stress conditions into
the extracellular space [12]. Soluble oligomeric forms of α-syn
have also been detected in the cerebrospinal fluid and sera of PD
patients [13–16].
α-Syn pathology can spread from cell to cell, in both
cell culture and in vivo models of PD, by exogenously
added oligomeric forms which then induce intracellular
aggregation and propagation of α-syn in adjacent cells, initiating
neuroinflammation [12,17]. Short fragmented α-syn amyloid
fibrils have also been reported to trigger endogenous α-syn
to aggregate and accumulate sustainably over several passages
in non-transfected and transfected SH-SY5Y cells [18]. The
morphology and characteristics of intracellular inclusions have
been demonstrated to be influenced by the variant of α-syn
seed applied. In neurons, astrocytes and mixed primary cells,
sonicated A53T fibrils seeded ‘flame-like inclusions’, whereas
small E46K fibrils prompted the formation of punctate round-
shaped structures depending on the form of α-syn expressed. In
addition, the inclusions could be transferred during passaging
in a prion-like manner [19]. Further evidence for the prion-like
seeding mechanism of α-syn has arisen from a variety of in vivo
experimentation at the cellular, intercellular and tissue levels
which has been strengthened by sporadic cases of transmission
in mesencephalic transplants of PD patients. Although evidence
points towards a prion-like transmission of α-syn, improved
cellular and animal models and longitudinal studies are essential
to make progress in this field of research [20]. Oueslati et al. [21]
also highlighted key aspects that have to be explored regarding
the sequence-specific homotypic self-templating of α-syn via
preformed fibrils or heterotypic seeding of α-syn acting in concert
with Aβ peptides or tau. As the addition and uptake of preformed
seeds or intracerebral inoculation of brain homogenates have been
investigated in culture and transgenic mice, important questions
remain to be answered about the initiating steps and course of
propagation in the anatomical context of PD. These events are
exacerbated by an imbalance of multiple cellular degradation
pathways (ubiquitin–proteasome system, autophagy–lysosome
pathway and other known proteolytic and cellular enzymes)
affecting clearance of misfolded α-syn and concurrent activation
of inflammatory responses [21].
The self-assembly of α-syn and the factors that modulate its
aggregation, i.e. pH, temperature, post-translational modifications
[22], ligands [23] and metals [24,25], have been extensively
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studied by a variety of biophysical methods. However, the use
of high-resolution biophysical methods, e.g. NMR spectroscopy,
in characterizing the heterogeneous soluble amyloidogenic
oligomers is hindered due to their low concentrations and transient
nature in solution. In contrast, ESI–ion mobility spectrometry
(IMS)–MS has unique advantages to determine the mass and
conformation of oligomeric assemblies in a rapid time frame
using femtomolar protein concentrations [26]. Ion mobility
measurements, accompanied by molecular modelling, permit
the assignment of possible geometries for unknown protein
complexes, and this gives valuable insights into the topology of
the oligomers [27,28]. In the present study, oligomeric forms of α-
syn [6,29] have been solubilized under MS-compatible conditions
by the use of ammonium acetate as a buffer to enable ESI–IMS–
MS analysis. Ion mobility experiments and molecular modelling
demonstrate that the oligomeric species present encompass dimers
to hexamers with various morphologies and suggest that assembly
follows an isotropic growth pathway. Higher-order oligomers
have collision cross-sectional areas () consistent with a ring-
like assembly. These MS data, in conjunction with cell viability
measurements, show that these oligomers lack the ability to induce
Ca2+ influx, but are able to induce intracellular aggregation in a
prion-like manner.
MATERIALS AND METHODS
Preparation of α-syn oligomers
Monomeric α-syn was expressed in Escherichia coli and purified
as described previously [30]. Oligomer preparation of both
seeding- and pore-forming-type oligomers used as positive
controls is fully described in the Supplementary Online Data and
in [6]. To make the MS-compatible oligomers (i.e. suitable for
ESI–IMS–MS analysis), 50 mM sodium phosphate buffer was
replaced with 50 mM ammonium acetate, pH 7.0. In protocol 1,
α-syn was dissolved at 7 μM in either buffer, containing 20%
ethanol for production of oligomers. After 4 h of incubation,
oligomers were lyophilized and resuspended with one-half of
starting volume in either buffer containing 10% ethanol, followed
by incubation with agitation for 24 h at 21 ◦C with open lids to
evaporate residual ethanol. Oligomers were then further incubated
for 6 days with closed lids at 21 ◦C. In protocol 2, α-syn
was dissolved at 7 μM in 50 mM sodium phosphate buffer,
containing 20% ethanol followed by overnight incubation at
21 ◦C with continuous shaking, the oligomers were concentrated
and separated from monomer using VivaSpin500 30 000 Da
molecular-mass cut-off columns (Sartorius).
Biochemical characterization
Procedures for epitope mapping by dot blotting, immuno-
cytochemistry, Ca2+ influx assay and MTT cell viability
assay followed standard procedures and are detailed in the
Supplementary Online Data.
ESI–IMS–MS data acquisition
All reagents and globular proteins were purchased from
Sigma–Aldrich. All spectra were collected using a Synapt G2
HDMS instrument (Waters) by use of gold-coated home-made
borosilicate nano-capillaries in positive-ion mode. Instrumental
settings for data acquisition were: capillary voltage of 1.70–
1.90 kV, cone voltage of 60 V, source temperature of 60 ◦C, trap
collision energy of 4.0 V, transfer collision energy of 10 V, trap
bias of 45, and backing pressure of 3.0–3.1 mbar (1 bar = 100
kPa). IMS separations were performed at T-wave velocities of
Trap: 311, IMS: 800 and Transfer: 200 m/s and T-wave amplitudes
of 4–15 V using 3.6 mbar pressure of nitrogen gas maintained
by a 90 ml/min gas flow. Mass calibration was carried out by
an infusion of CsI cluster ions and the drift time cross-section
function was calibrated as described previously [27,31]. Drift
times were corrected for both mass-dependent and -independent
TOF [27].
Molecular modelling
In silico  were calculated utilizing a modified version of
the projection approximation script developed by the Ashcroft
group [31,32]; the modified source code is available from
https://github.com/tumbling-cross-section. Modifications to the
original script included a change in the sweep patterns to a used
a Fibonacci ‘Pinecone’ grid instead of the latitude–longitude
scan [33] and the ability to use atomic radii of any value. In
silico models were then created assuming the monomeric α-syn
subunit was spherical with a radius of 19.9 Å (1 Å = 0.1 nm)
which is comparable to the most compact observed form of the
monomer measured here. Oligomers were modelled by allowing
a 4 or 8 Å overlap between different subunits, giving a centre-to-
centre distance of 36 or 32 Å which is comparable to the most
compact forms of the dimer measured here. Models were then
constructed by placing atoms 36 Å apart either in a sequential
linear arrangement or by placing the centre of the spheres at the
points of regular polygons in which the sides were 36 or 32 Å in
length. The radius of the carbon atoms was set to 19.9 Å within the
atomic radii library used by the projection approximation script.
Supplementary Figure S1 shows an example of a hexagonal ring
arrangement and associated PDB file.
RESULTS
In vitro, α-syn oligomers with distinct biophysical properties are
associated with alternative mechanisms of neurotoxic activity,
and protocols have been described for their production [6,29].
The gain-of-function is dependent on the method of oligomer
preparation and falls into two main types: those with pore-
forming capabilities which are able to induce Ca2+ influx
resulting in cell death and those with seeding capabilities that are
able to induce intracellular aggregation in a prion-like manner.
Predominantly, these protocols use sodium phosphate or Tris
as the buffer and these are both incompatible with MS; hence,
the present study replaced the buffer with ammonium acetate
which is MS-compatible. Oligomer formation was induced in
ammonium acetate buffer following protocol 1 and the resulting
oligomers were characterized by ESI–IMS–MS. The biochemical
behaviour of the oligomers produced in ammonium acetate was
then determined through comparisons with oligomers produced in
sodium phosphate that have either pore-forming or intracellular-
seeding abilities.
Native mass spectrometry to study molecular organization
ESI–IMS–MS allows the subunit size and gross morphology
of protein complexes to be determined through the acquisition
of . These experimental results can then be compared with
model structures to decipher the mechanism of assembly.
Optimal instrumental settings were established and spectra of
a range of globular proteins were acquired (Supplementary
Table S1) [31,34]. Each of the spectra of the globular proteins
displayed a narrow charge state distribution (CSD) indicative
of a folded protein. Increasing the activation energies also
resulted in increased  as the protein unfolded (results not
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
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Figure 1 Comparison of ESI–MS spectra of 7 μM α-syn acquired in 50 mM ammonium acetate and 20% ethanol, pH 7.0
(A) Oligomers observed post-assembly and (B) monomeric α-syn in 50 mM ammonium acetate (pH 7.0) acquired immediately upon the addition of 20% ethanol showing the lack of any pre-existing
oligomeric species. The x-axis represents m/z values, the y-axis is relative abundance (%). The region >2900 m/z was enlarged by 82-fold to visualize any of the lower-abundance oligomeric
series.
shown), demonstrating that the proteins retain a native like
conformation within our experiments. The monomeric form of
α-syn is considered a natively disordered protein as it displays
considerable conformational heterogeneity [35,36]. Analysis of
WT α-syn before the addition of cofactors and ethanol revealed
a primarily extended population (charge state ions + 8 to + 18)
and a sub-population of a more compact conformational series
(charge state ions + 6 to + 8) with multiple overlapping features
consistent with previous data [34,37] (Figure 1). Critically,
oligomeric forms were not detected immediately upon solvation
and the addition of 20% ethanol, indicating that oligomers
assemble as a result of the preparation protocols and are not
induced by the act of spectral acquisition.
ESI–IMS–MS data were acquired to probe the structural
properties of the α-syn oligomers assembled in ammonium
acetate. Compactness and subunit arrangement of the oligomers
were addressed through calculation of  for each charge
state observed following established procedures [27,31]. Each
oligomeric state was assigned based on multiples of the theoretical
mass of the unmodified monomer. The mass spectrum and
Driftscope plot of the α-syn oligomers revealed a range of
oligomers from dimers to hexamers alongside both extended
and compact populations of monomeric protein (Figures 1A
and 2A). The presence of monomers to hexamers indicated that
oligomer assembly progresses in an isotropic manner, recruiting
one monomer at a time as oligomer size increased. To determine
the gross morphological features of the oligomers,  were
obtained for each of the charge state ions and compared with
 of the globular protein structures (Supplementary Table S1).
Figure 2B shows the meanwith the spread of the observed data
for oligomers. The measured  of the globular standards was
then used to back-calculate theoretical  assuming a spherical
structure for a protein of a given mass (Figure 2B, black line).
The mean  of α-syn dimer was greater than that of porcine
elastase and carbonic anhydrase (29 090 Da). The  of α-
syn trimer was larger than the alcohol dehydrogenase (ADH)
monomer (39 804 Da), whereas the α-syn pentamer  (72 300
Da) was greater than the  of the albumin monomer (66 463
Da). These results indicate that oligomers have a greater  than
globular proteins of a comparable mass. In order to better illustrate
the spread of resulting from each oligomeric state, the observed
 resulting from each charge state ion were plotted as a function
of subunit sizes (Figure 3). Proteins that are unfolded are known
to display a characteristic broad CSD, whereas folded globular
proteins display a narrow CSD with a predicable mean charge
[38]. The spread of dimers was quite remarkable in that the
recorded range of  was 2407–4013 Å2 with a CSD from + 9 to
+ 16 indicating a population of highly expanded to collapsed
conformations. As the oligomer size increased, the range of
experimental  measured decreased with the trimers spanning
 of 3365–4454 Å2, the tetramers spanning  of 4279–4695 Å2,
the pentamers spanning  of 4657–5015 Å2 and the hexamers
spanning  of 5414–5605 Å2. The increase in oligomer size also
resulted in narrower CSD; for example, the tetramers had a CSD
of + 16 to + 18, the pentamers displayed charge state ions of
+ 17 to + 20, and hexamers obtained + 18 to + 21 charges.
The measured  and CSD revealed that an increase in oligomer
size resulted in increasingly compact oligomeric states with the
pentamer and hexamer displaying a narrow CSD indicative of
folded proteins [39]. The narrow CSD and relatively small 
demonstrated that the higher-order oligomers obtain a compact
conformation as they assemble as opposed to the structurally
diverse and expanded states of the lower-order oligomers. The
mean experimentally measured  of the α-syn oligomers were
greater than that of predicted globular proteins, suggesting that
they occupy more volume than the globular standards. The
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
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Figure 2 Driftscope plot of MS compatible oligomers with a comparison of
 as a function molecular mass
(A) Driftscope plots and m/z spectra of α-syn oligomers. α-syn peaks were extracted from
the Driftscope plots and the region>2900 m/z was enlarged to visualize the lower-abundance
higher-order oligomeric series. Oligomers fell into the populations of dimers (2), trimers (3),
tetramers (4), pentamers (5) and hexamers (6). (B) Comparison of  of α-syn oligomers
(black circles) with that of globular protein standards (white circles) under native conditions.
All measurements were carried out in triplicate and plotted as the mean over all charge states
against molecular mass (Mr). Error bars show the spread in  for monomeric (M), dimeric
(D), trimeric (T), tetrameric (Q), pentameric (P) and hexameric (H) species; for details see
Supplementary Table S1. The spread in for the known globular standards can also be found
in Supplementary Table S1. (black line). Theoretical  were calculated for a range molecular
masses assuming a perfect sphere of density 0.37 Da/A˚3.
lower-order oligomers, indicated by their broad CSD, appear to be
structurally diverse. However, the higher-order oligomers display
a more compact structure indicated by the narrow CSD.
Modelling the topology of the oligomers
Computational approaches in conjunction with ESI–IMS–MS
provide additional information when determining the potential
geometries and structural features of multi-subunit systems
[27,28]. To ascertain the topology of the oligomers,  were
compared with theoretically derived  for a range of oligomeric
conformations using a projection approximation algorithm [31].
This modelling approach assumes that the monomeric subunits of
the higher-order oligomers are composed of fully folded sphere
units with a 19.9 Å radius. This assumption is based on the narrow
Figure 3  of α-syn oligomers as a function of subunit size alongside
model structures
 of each charge state ion are plotted according to oligomer size (white circles). The x-axis
is subunit size and the y-axis shows  in A˚2. Expected  of model spherical structures with
the same mass as the oligomers based on the globular protein standards are shown as black
circles. Models were constructed by arranging subunits as spheres with a radii of 19.9 A˚ whose
 is comparable to the most compact state of the monomer. Subunits were arranged either
linearly (black lines), as ring and open ring arrangements with a centre-to-centre spacing of 36
A˚ (grey lines) or as a compact closed ring arrangement with a centre-to-centre spacing of 32 A˚
(white lines). A schematic representation of each of the models is shown above using the same
colouring system.
CSD observed for the higher-order oligomers and each individual
subunit being comparable to the most compact observed form
of the monomer measured here (Figure 2). A 4 or 8 Å overlap
between different subunits was allowed, giving a centre-to-centre
distance of 36 or 32 Å which is comparable to the most compact
forms of the dimer measured here. This modelling approach is
similar to that used for the oligomers involved in Alzheimer’s
disease [40]. A range of conformations including linear structures,
closed ring and open ring forms have been constructed to model
the experimentally acquired  with centre-to-centre distance of
36 or 32 Å. The data were plotted alongside experimentally
determined  for the oligomers of α-syn (Figure 3). Fully linear
models and ring-like structures in which subunits are arranged
with a spacing of 36 Å overestimated the observed  of the
pentamers and hexamers. However, if the monomeric subunits
were sequentially removed from this model in silico to create an
open ring structure, then the most compact state of the tetramer
could be modelled at 36 Å spacing. Partially collapsed models
in which the oligomeric subunits are composed of a folded core
made up of 100 amino acids with 40-amino-acid unstructured
termini were also constructed (Supplementary Figure S2). These
models are comparable with the more extended states of the
tetramer but again overestimates the hexamer, supporting the
notion that the higher-order oligomers are composed of compact
subunits without the presence of unstructured termini. In order
to model the experimental data compact closed rings with a
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
Compact α-synuclein oligomers induce intracellular aggregation 489
Figure 4 Epitope mapping profiles of α-syn monomer, fibrils and alternate oligomers
Epitope mapping studies of different oligomeric populations performed using mouse monoclonal antibodies, polyclonal anti-α-syn antibody (Poly) and anti-oligomer A11 antibody. Binding profile
of monomer, fibril, pore-forming and seeding oligomers in ammonium acetate with polyclonal antibody, anti-α-syn antibody and monoclonal antibodies.
centre-to-centre distance of 32 Å were created. These models
closely matched the observed experimental data for the hexamers
and pentamer suggesting a compact ring-like arrangement for
these oligomers. Fully spherical structures or closely packed
arrangements underestimated the experimental data. Modelling
the experimental data combined with the  and CSD analysis
shows that as the oligomers assembled under MS-compatible
conditions they become more compact structures, which are
consistent with ring-like assemblies.
Oligomeric species show distinct epitopes by dot blotting
Dot blotting procedures are a standard method to determine
the availability of antigenic conformational epitopes on the
surface of oligomeric, protofibrillar or fibrillar species [41–44].
The α-syn oligomers were subjected to dot blotting with a
rabbit polyclonal antibody (Poly) raised against full-length α-
syn (Figure 4). All the samples bound to the Poly antibody except
the BSA control, showing both specificity of the antibody and
that all the oligomer samples contained α-syn protein (Figure 4).
Oligomers were also probed with the conformation-dependent
anti-oligomeric A11 antibody, which identifies oligomers linked
to the Ca2+ influx toxic gain-of-function [45]. The oligomers
prepared by protocol 1 (i.e., in sodium phosphate buffer) gave
a strong fluorescent signal when probed with A11 (Figure 4).
However, the oligomers produced in ammonium acetate (MS
compatible) by this same protocol were only weakly reactive with
A11, indicating that alternative structures may be present and/or
there is a reduced yield. The monomer, fibrils and intracellular
seeding oligomers were all unreactive to A11. In addition, a
panel of mouse monoclonal antibodies denoted W, X, Y and Z
(see the Supplementary Materials and methods section) directed
against different epitopes of the three main domains (N-terminus,
central region and C-terminus) of α-syn were used. Antibody
W (N-terminal region) only detected the pore-forming oligomers
prepared by protocol 1 in sodium phosphate buffer and none of the
other forms. Monoclonal antibody X (mid-region) reacted with
all the oligomers except the pore-forming oligomers, indicating
that the epitope is buried and unavailable to bind. Monoclonal
antibody Y (C-terminal region) detected all oligomeric species,
indicating that this region is exposed and accessible on all species.
However, monoclonal antibody Z (C-terminal region) which
overlaps with monoclonal with Y only showed reactivity with
the seeding-type oligomers and the MS-compatible oligomers.
This demonstrates that monoclonal antibodies Y and Z span
a conformational hotspot in α-syn that is altered between the
oligomeric forms. These results yielded a characteristic pattern
for each oligomer type prepared in sodium phosphate buffers.
MS-compatible oligomers assembled using ammonium acetate
as a buffer displayed an epitope-binding pattern consistent with
an intracellular seeding type (Figure 4).
Ca2+ influx and neurotoxicity
The dot blotting results predicted that the pore-forming oligomers
produced by protocol 1 in sodium phosphate buffer would have
Ca2+ channel-like behaviour due to their ability to bind the A11
antibody and the MS-compatible oligomers would be largely
inactive in this assay. To test this hypothesis, the ability of each
oligomeric type to induce Ca2+ influx was measured. SH-SY5Y
neuroblastoma cells were cultured and loaded with a FLIPR
Calcium 6-QF Ca2+ sensitive dye before treatment with the
different oligomeric species [6]. As predicted, the pore-forming
oligomers caused a rise in intracellular Ca2+ levels comparable to
that caused by positive control ionomycin (Figure 5). None of the
other oligomer types or controls (monomer and α-lactalbumin)
had a comparable effect on intracellular Ca2+ levels. MTT
viability assays performed at the same time point showed no
significant loss in cell viability, indicating that Ca2+ influx was
not a secondary effect of cell death (Supplementary Figure
S3). After 48 h of treatment, only the pore-forming oligomers
reduced the viability of the human neuroblastoma cells to
statistically significant levels (Figure 6). These findings are in
agreement with Danzer et al. [6], who showed that this oligomer
type activated caspase-3 leading to apoptotic cell death. MS-
compatible oligomers displayed a reduction in cell viability in
accordance with the weak A11 reactivity (Figure 6).
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
490 E. Illes-Toth and others
Figure 5 Ca2+ influx induced by the addition A11 positive oligomers
Ca2+ influx of SH-SY5Y human neuroblastoma cells performed at 1.0× 105 cells/well seeding
density. Appropriate solvents were subtracted and means have been plotted +
−
S.E.M., n = 3,
**P < 0.001 and ***P < 0.0001.
Figure 6 SH-SY5Y cell viability in the presence of α-syn monomer, fibrils
and alternate oligomers
MTT cell viability assay of SH-SY5Y human neuroblastoma cells performed at 1.0× 105
cells/well seeding density after 48 h of incubation with oligomers originating from protocol 1 or
protocol 2 and MS-compatible oligomers alongside respective controls at 10% (v/v). Means
are plotted +
−
S.E.M., values have been normalized to untreated cells (100%). **P < 0.001,
***P < 0.0001.
Intracellular aggregation properties
Certain forms of α-syn located in the extracellular environment
can be internalized and induce endogeneous α-syn to self-
aggregate [6,18,46–49]. This may represent a mechanism for the
spread of aggregated α-syn in the PD brain. To test the propensity
of our oligomers to induce intracellular aggregation of α-syn, SH-
SY5Y cells overexpressing A53T α-syn were exposed to each
oligomer preparation as well as to the monomer and solvent
controls (Figure 7). Treatment with the intracellular seeding
oligomers produced by protocol 2 in sodium phosphate buffer
caused a marked reduction in the homogeneous cytoplasmic
staining ofα-syn and resulted in an increase in punctate aggregates
in the cytosol, consistent with Danzer et al. [29] (Figure 7B). In
contrast, the A11-reactive pore-forming oligomers did not show
any altered cytoplasmic staining, indicating that this form of
oligomer lacked the ability to induce intracellular aggregation
(Figure 7A).
MS-compatible oligomers had an enhanced ability to induce
intracellular aggregation (Figure 7D). This correlated with their
dot blotting profile which matched the intercellular seeding
oligomers. Exposure to monomeric α-syn and the solvent controls
did not result in aggregation (Figures 7C and 7F). The SH-
SY5Y cells incubated with the MS-compatible oligomers for
20 min did not show any intracellular aggregation (Figure 7E).
This demonstrated that formation of the punctate intracellular
aggregates in Figures 7B and 7D was time-dependent and the
observed punctuate aggregates were not an artefact brought about
by pre-formed oligomers binding to the outside of the cell.
DISCUSSION
The properties of in vitro generatedα-syn oligomers, with disease-
relevant toxicity and aggregation properties, are dependent on the
manner of preparation, resulting in either pore-forming or seeding
types [6]. To understand the structure–function relationships of
the α-syn oligomers, we modified the preparation protocols (by
varying the buffer conditions) to allow them to be characterized
by ESI–IMS–MS. In order to have a point of comparison for the
oligomers produced under MS-compatible conditions, positive-
control oligomers for both seeding and pore-forming oligomers
were produced using previously described protocols. Seeding-
type oligomers were non-toxic but able to induce intracellular
aggregation, whereas the pore-forming oligomers were reactive
to the anti-oligomer antibody A11 and brought about Ca2+ influx.
In the present study, we have demonstrated that these positive-
control oligomers have distinct differences in their surface-
accessible epitopes with the MS-compatible oligomers produced
in ammonium acetate matching the seeding-type oligomers
produced in sodium phosphate. This similarity to the seeding-
type oligomer was supported by the MS-compatible oligomers
also being able to promoting intracellular seeding in cell culture.
Only the pore-forming positive-control oligomers produced in
sodium phosphate were able to induce toxicity and bind strongly to
the A11 antibody. Some A11 binding was observed with the MS-
compatible oligomers which had the ability to induce toxicity. The
lyophilization step in protocol 1 may be critical for the increased
formation of the A11-reactive species. Since ammonium acetate
is a volatile buffer it will be removed by lyophilization, whereas
sodium phosphate will remain. Hence the final ionic strength
of the buffer on solubilization in the MS-compatible protocol
will be lower as the volatile buffer has been removed. This
difference in ionic strength presumably pushes the protein along
one of two potential aggregation pathways upon resolubilization.
By changing the assembly buffer from sodium phosphate to
ammonium acetate, oligomers capable of intracellular seeding
were produced.
The structure and topology of these oligomeric species
were characterized by ESI–IMS–MS and found to co-populate
dimers to hexamers, in addition to the presence of monomeric
conformations. The presence of monomers to hexamers within
the samples indicates isotopic growth and subunit assembly by
monomer addition. Other groups, using alternative methods,
have observed oligomer distributions akin to those seen here.
Single-molecule FRET analysis has detected a range of α-
syn oligomeric species that undergo a conformational change,
resulting in higher-order oligomers and an increased resistance
to proteinase K digestion over time [10]. The initial subset of
oligomers ranged from dimers to pentamers in size and was
prepared at the same concentrations used here. Therefore, it
is possible that the oligomers characterized here represent the
same initial subset of oligomers prior to their reorganization.
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
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Figure 7 SH-SY5Y cells overexpressing the A53T α-syn variant were treated with 10% (v/v) pre-formed oligomers, monomers or solvent for 8 h or 20 min
Immunofluorescent staining was performed with the A11 antibody (red staining) after treatment with 10% (v/v) α-syn oligomers or matched solvent controls and was detected by Alexa Fluor®
495-conjugated goat anti-mouse antibody. DAPI staining appears blue; 100× magnification. The arrows indicate cells with punctate formation as a result of intracellular aggregation. Cells were
treated with (A) pore-forming oligomers, (B) seeding-type oligomers, (C) α-syn monomer, (D) MS-compatible oligomers, (E) MS-compatible oligomers after a short incubation of 20 min and (F)
ammonium acetate buffer vehicle control.
In vivo, oligomers characterized recently by number and
brightness analysis in live SH-SH5Y cells also show a similar
size range encompassing maximum 6+− 4-mers, similar to our
observations [50]. α-Syn is known to co-populate a range of
conformational states as observed by ESI–IMS–MS. Our previous
ESI–IMS–MS analysis of wild-type α-syn revealed a primarily
extended population (∼2482+− 159 Å) and a subpopulation
of two compact conformational series (∼1851+− 276 Å) with
multiple overlapping features and a less observable dimeric
species under native conditions [37] in accordance with previously
published research [34]. The Barran group recently reported
that α-syn displays a broad CSD ranging from + 5 to + 21
with a  of approximately 1600 Å. Chemical cross-linking
with IMS–MS measurements revealed three main conformational
families, a compact (∼1200 Å), an extended (∼1500 Å) and
an unfolded (∼2530 Å) state that are similar to monomeric
conformers present in solution [51]. The existence of three distinct
conformational states is in agreement with our observations;
the inconsistencies between our  and those reported by this
group may arise from experimental conditions including type of
instrumentation, protein concentration and buffer conditions.
Lower-order oligomers, in particular the dimers described in [51],
had resulted from an alternative preparation protocol yet they were
in agreement with our results reflecting conformationally dynamic
entities. Przybylski and co-workers [52] have also undertaken
characterization of α-syn oligomers by gel electrophoresis, N-
terminal Edman sequencing and ion mobility measurements. Full-
length monomeric and dimeric α-syn, proteolytic and truncated
sequence fragments were identified in their investigations [52]. No
higher-order oligomers were reported despite the use of similar
preparation protocols to those discussed here. This may be due to
the use of a desalting column operated at a gradient of 10–90 %
acetonitrile prior to IMS instrumentation which may disassemble
the oligomers [52]. To determine the structural organization of
the oligomers observed here  were calculated and revealed that
as the subunit size increases, the oligomers become increasingly
more compact. Lower-order oligomers (dimers and trimers) are
structurally diverse and populate a broad range of . Oligomers
of the pentameric and hexameric series had very narrow CSD
and little spread in their , as compared with the lower-order
oligomers and adopted structures that are consistent with a
compact ring-like assembly that could not be fitted as linear,
partially folded or spherical structures. This potentially compact
ring model would explain why higher-order oligomers (n>6)
are not observed in the spectra as the further addition of
monomers would require the ring-like structure to be broken
and a conformational change to occur. The compact nature of
the oligomers would protect them from degradation by proteases,
allowing them to move from cell to cell and transmit pathology.
Similar oligomeric conformations have been documented in the
case of Aβ42 (where Aβ is amyloid β-peptide) oligomers, with
dimers, tetramers, hexamers and dodecamers being observed
and correlated with toxicity, but no odd number oligomers
were detected. The higher-order oligomers obtained a ring-like
structure very similar to that observed in our study [40,53]
and ring assemblies have been observed by other methods such
as AFM [54]. The structural collapse and assembly of α-syn
seen on aggregation also has precedents. β2-Microglobulin self-
aggregation proceeds by monomeric addition at pH 2.5 where
the initially highly expanded monomeric states collapse upon
assembly to higher-order oligomers. However, in that system, the
monomers to tetramers are more extended with consistent with
elongated structures and do not display the same toxic behaviour
as Aβ42 and α-syn oligomers [55]. The energetics and complexity
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
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governing the early stages of α-syn oligomerization has been
illustrated by molecular modelling studies using a projection
approximation algorithm which showed that each aggregated
form of dimers, trimers and tetramers could have a number of
different morphologies [56] akin to the dispersed observed here.
Although we cannot rule out higher-order species being present,
they were not observed by ESI–IMS–MS as was the case for the
single-molecule FRET experiments [10]. Future investigations
should focus on an in-depth analysis of the kinetics and stability
of these α-syn oligomers and how that correlates to toxicity and
propagation.
From the results we have gathered here, we speculate that
compact higher-order ring-like oligomers are associated with
intracellular seeding. This proposal provides a guide for directing
efforts towards the isolation of the toxic forms α-syn in vivo. As
such, it would be highly desirable to obtain more comprehensive
information about α-syn oligomers that have been detected in
the cerebrospinal fluid and sera of PD patients [13–16] through
the epitope mapping used here. The challenge will remain to
isolate oligomers from clinical specimens of PD patients or
other biological systems under near-native conditions [57,58] and
elucidate how the oligomers produced in vivo compare with those
observed here.
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